VC

Vivo Capital Portfolio holdings

AUM $977M
This Quarter Return
+13.76%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
AUM
$2.23B
AUM Growth
+$2.23B
Cap. Flow
-$165M
Cap. Flow %
-7.42%
Top 10 Hldgs %
65.91%
Holding
64
New
5
Increased
3
Reduced
16
Closed
4
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ALXO icon
1
ALX Oncology
ALXO
$62.7M
$312M 14% 4,220,048
TIL icon
2
Instil Bio
TIL
$182M
$223M 10.02% 12,486,787
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$187M 8.41% 4,884,341 +350,000 +8% +$13.4M
NFH
4
DELISTED
New Frontier Health Corporation Ordinary Shares
NFH
$161M 7.21% 14,300,000
AMRS
5
DELISTED
Amyris Inc.
AMRS
$160M 7.18% 11,642,195 +2,266 +0% +$31.1K
ASND icon
6
Ascendis Pharma
ASND
$11.8B
$121M 5.44% 760,606 -765,753 -50% -$122M
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$96.9M 4.35% 5,966,527
GTH
8
DELISTED
Genetron Holdings Limited ADS
GTH
$87.8M 3.94% 6,339,860
TARS icon
9
Tarsus Pharmaceuticals
TARS
$2.47B
$64.4M 2.89% 2,987,331
ALGS icon
10
Aligos Therapeutics
ALGS
$73.3M
$55M 2.47% 3,547,030
BOLT icon
11
Bolt Biotherapeutics
BOLT
$9.85M
$49M 2.2% 3,871,291
SRRA
12
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$42M 1.89% 1,917,074
WHWK
13
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
$41.9M 1.88% +1,427,213 New +$41.9M
SVA
14
DELISTED
Sinovac Biotech, Ltd
SVA
$38.2M 1.71% 5,900,000
KDMN
15
DELISTED
Kadmon Holdings, Inc.
KDMN
$37.3M 1.68% 4,283,014 -1,534,445 -26% -$13.4M
IMPL
16
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$35.1M 1.58% 2,884,789
OLMA icon
17
Olema Pharmaceuticals
OLMA
$375M
$34.1M 1.53% 1,238,575
AVDL
18
Avadel Pharmaceuticals
AVDL
$1.43B
$28.8M 1.29% 2,937,093
KALV icon
19
KalVista Pharmaceuticals
KALV
$678M
$28.7M 1.29% 1,641,913 -221,383 -12% -$3.86M
TERN icon
20
Terns Pharmaceuticals
TERN
$609M
$27.9M 1.25% 2,675,133
CLDX icon
21
Celldex Therapeutics
CLDX
$1.47B
$26.2M 1.17% 484,453 -484,453 -50% -$26.2M
LEGN icon
22
Legend Biotech
LEGN
$6.41B
$24.7M 1.11% 488,751 -467,951 -49% -$23.7M
VRDN icon
23
Viridian Therapeutics
VRDN
$1.5B
$21.4M 0.96% +1,300,000 New +$21.4M
SERA icon
24
Sera Prognostics
SERA
$123M
$20.6M 0.93% +1,856,011 New +$20.6M
ZLAB icon
25
Zai Lab
ZLAB
$3.68B
$18.4M 0.83% 174,999 -1 -0% -$105